Advertisement

Topics

GelTex Incorporated Company Profile

14:21 EDT 30th May 2016 | BioPortfolio

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialysis patients.

In addition, WelCholTM brand colesevelam hydrochloride was granted marketing approval by the FDA in May 2000, for the treatment of hypercholesterolemia, a condition characterized by undesirably high blood cholesterol levels.

Location

153 Second Avenue
Waktham
MA
02451
United States of America

Contact

Phone: 781 290 5888
Fax: 781 290 5890


News Articles [6 Associated News Articles listed on BioPortfolio]

TransDigm Group Incorporated and Breeze-Eastern Corporation Announce Acquisition Agreement

CLEVELAND and WHIPPANY N.J., Nov. 19, 2015 (GLOBE NEWSWIRE) -- TransDigm Group Incorporated ("TransDigm") (NYSE:TDG) and Breeze-Eastern Corporation ("Breeze-Eastern") (NYSE MKT:BZC) today announced a...

CATERPILLAR INCORPORATED - Dividend Declaration

Caterpillar Inc. Maintains Dividend Rate PEORIA, Illinois, Dec. 9, 2015 -- The Board of Directors of Caterpillar Inc. (NYSE: CAT) voted today to maintain the quarterly cash dividend of seventy-sev...

CATERPILLAR INCORPORATED - Form 8-K

CATERPILLAR INC. FILES FORM 8-K PEORIA, Illinois, April 22, 2016 - Caterpillar Inc. (NYSE: CAT/Euronext: CATR) informs its stockholders that today Caterpillar Inc. furnished a Form 8-K to the SEC ...

CATERPILLAR INCORPORATED - Caterpillar to Participate in Wells Fargo Conference

Caterpillar to Participate in the Wells Fargo Securities Industrial and Construction Conference on May 11; Webcast Available PEORIA, Ill., May 9, 2016 -- Caterpillar Inc. (NYSE: CAT) Group Preside...

CATERPILLAR INCORPORATED - Notice of Results

Caterpillar Inc. to Announce Full-Year and Fourth-Quarter 2015 Financial Results on January 28 PEORIA, Ill., Jan. 14, 2016 -- Caterpillar Inc. (NYSE: CAT) will release full-year and fourth-quarter...

Corcept Therapeutics to Announce Preliminary 2015 Financial Results, Provide 2016 Revenue Guidance and Corporate Update, and Host Conference Call

MENLO PARK, CA -- (Marketwired) -- 01/21/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report preliminary fourth quarter and full year 2015 financial results and prov...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

GelTex Pharmaceuticals Incorporated

GelTex Pharmaceuticals, Inc. is developing non-absorbed, polymer-based pharmaceuticals that selectively bind to andeliminate target substances from the intestinal tract. In October 1998, the Company r...

GelTex Incorporated

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s ...

More Information about "GelTex Incorporated" on BioPortfolio

We have published hundreds of GelTex Incorporated news stories on BioPortfolio along with dozens of GelTex Incorporated Clinical Trials and PubMed Articles about GelTex Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GelTex Incorporated Companies in our database. You can also find out about relevant GelTex Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record